Sinocare

Sinocare ROCE

The Return on Capital Employed (ROCE) of Sinocare (300298.SZ) as of Oct 23, 2026 is 2.81 %. In the previous year, Return on Capital Employed (ROCE) was 10.58 % — a change of -73.49% (lower).

ROCE

2.81 %

YoY

-73.49%

Last updated:

In 2025, Sinocare's return on capital employed (ROCE) was 2.81 %, a -73.49% increase from the 10.58 % ROCE in the previous year.

The Sinocare ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2018
12.13 CNY
Jan 1, 2019
10.43 CNY
Jan 1, 2020
13.12 CNY
Jan 1, 2021
4.99 CNY
Jan 1, 2022
12.44 CNY
Jan 1, 2023
7.92 CNY
Jan 1, 2024
10.58 CNY
Jan 1, 2025
2.81 CNY
The Sinocare ROCE history
YEARROCEYoY
2.81 %-73.49%
10.58 %+33.57%
7.92 %-36.29%
12.44 %+149.36%
4.99 %-61.97%
13.12 %+25.71%
10.43 %-13.98%
12.13 %-43.33%
21.40 %+275.83%
5.70 %-48.83%
11.13 %-37.54%
17.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sinocare Stock analysis

What does Sinocare do? Sinocare, Inc. generates revenue through the development, production, and sale of chronic disease rapid detection products, primarily focusing on blood sugar monitoring systems. The company offers blood sugar testing instruments, related strips, blood sugar testing systems, and mobile blood sugar instruments under its SANNUO brand. These products are sold domestically and internationally, targeting healthcare providers and consumers managing diabetes. Sinocare also provides diabetes management information systems as part of its product portfolio. The SANNUO brand is central to Sinocare's sales strategy, with products distributed across domestic and overseas markets. The company's offerings include micro blood instant blood sugar monitoring systems, which are designed for chronic disease management. Sinocare's revenue streams are derived from direct sales of these medical devices and associated information systems to end-users and healthcare institutions. Sinocare's business model relies on the consistent demand for diabetes management solutions, with its SANNUO-branded products serving both individual consumers and healthcare facilities. The company's product range includes blood sugar testing instruments, strips, and mobile blood sugar instruments, all marketed under the SANNUO label. These products are distributed globally, supporting Sinocare's revenue generation through direct sales channels. Sinocare is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Sinocare's Return on Capital Employed (ROCE)

Sinocare's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Sinocare's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Sinocare's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Sinocare’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Sinocare stock

Return on Capital Employed (ROCE) of Sinocare is 2.81 % in 2025.

Return on Capital Employed (ROCE) of Sinocare changed from 10.58 % to 2.81 %, representing a -73.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Sinocare since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Sinocare with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Sinocare

All Key Metrics — Sinocare